Home Cart Sign in  
Chemical Structure| 499-44-5 Chemical Structure| 499-44-5

Structure of Hinokitiol
CAS No.: 499-44-5

Chemical Structure| 499-44-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hinokitiol, an iron chelator originally extracted from woods of Thuja plicata and Chamaecyparis obtuse, has been found to inhibit ultraviolet B-induced apoptosis in keratinocytes of murine ear skin via antioxidant activity of metallothionein. It can partially mimic the function of missing protein transporters of iron, and possibly other ions, may have potential in treating human diseases.

Synonyms: β-Thujaplicin; NSC 18804; 4-Isopropyltropolone

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hinokitiol

CAS No. :499-44-5
Formula : C10H12O2
M.W : 164.20
SMILES Code : O=C1C(O)=CC(C(C)C)=CC=C1
Synonyms :
β-Thujaplicin; NSC 18804; 4-Isopropyltropolone
MDL No. :MFCD00040180
InChI Key :FUWUEFKEXZQKKA-UHFFFAOYSA-N
Pubchem ID :3611

Safety of Hinokitiol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312+P330-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
FPN1-deficient J774 macrophages 1 μM Restored iron release in FPN1-deficient cells Science. 2017 May 12;356(6338):608-616
PANC-1 human pancreatic cancer cells 80 μg/mL 10 h To evaluate the effect of Hinokitiol on iron content and mitochondrial function in mammalian cells. Results showed that Hinokitiol had minor effects on iron content and mitochondrial function in mammalian cells, indicating selectivity towards fungal cells. J Adv Res. 2021 Jun 17;34:65-77
BEAS-2B human bronchial epithelial cells 80 μg/mL 10 h To evaluate the effect of Hinokitiol on iron content and mitochondrial function in mammalian cells. Results showed that Hinokitiol had minor effects on iron content and mitochondrial function in mammalian cells, indicating selectivity towards fungal cells. J Adv Res. 2021 Jun 17;34:65-77
Candida albicans SC5314 2-8 μg/mL 30 min to 10 h To evaluate the effect of Hinokitiol on fungal intracellular iron content and its inhibition of mitochondrial respiration. Results showed that Hinokitiol significantly reduced intracellular Fe2+ levels, inhibited the activities of mitochondrial respiratory chain complexes I and II, leading to decreased mitochondrial membrane potential and ATP production. J Adv Res. 2021 Jun 17;34:65-77
Mfrn1-deficient MEL cells 1 μM Restored iron uptake and hemoglobinization in Mfrn1-deficient cells Science. 2017 May 12;356(6338):608-616
DS19 murine erythroleukemia (MEL) cells 1 μM 3 days Restored iron uptake, iron-heme incorporation, and hemoglobinization in DMT1-deficient cells Science. 2017 May 12;356(6338):608-616
Caco-2 gut epithelial cells 500 nM Restored iron uptake and transepithelial iron transport in DMT1-deficient monolayers Science. 2017 May 12;356(6338):608-616
Kupffer cells 5 μM 60 minutes restore iron transport and reduce intracellular iron accumulation Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2121400119
RAW264.7 macrophages 5 μM assess iron release and intracellular labile iron levels Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2121400119
HL-7702 cells 25, 50, 100, 200, 400 nM 24, 48, 72 hours To evaluate the cytotoxicity of β-Thujaplicin on normal liver cells, results showed that β-Thujaplicin had minimal effect on the growth of HL-7702 cells Cell Death Dis. 2019 Mar 15;10(4):255
HCCLM3 cells 25, 50, 100, 200, 400 nM 24, 48, 72 hours To evaluate the cytotoxicity of β-Thujaplicin on HCC cells, results showed that β-Thujaplicin significantly inhibited the growth of HCCLM3 cells in a dose-dependent manner Cell Death Dis. 2019 Mar 15;10(4):255
SMMC-7721 cells 25, 50, 100, 200, 400 nM 24, 48, 72 hours To evaluate the cytotoxicity of β-Thujaplicin on HCC cells, results showed that β-Thujaplicin significantly inhibited the growth of SMMC-7721 cells in a dose-dependent manner Cell Death Dis. 2019 Mar 15;10(4):255
HepG2 cells 25, 50, 100, 200, 400 nM 24, 48, 72 hours To evaluate the cytotoxicity of β-Thujaplicin on HCC cells, results showed that β-Thujaplicin significantly inhibited the growth of HepG2 cells in a dose-dependent manner Cell Death Dis. 2019 Mar 15;10(4):255
CRL-8024 cells 10–100μM To evaluate the effect of hinokitiol on HCC cell proliferation, results showed that hinokitiol significantly attenuated the proliferation of HCC cell lines in a dose-dependent manner while downregulating the protein levels of UHRF1, GLI1, CD44, and CD133. Cell Death Dis. 2023 Jun 28;14(6):381
MEL cells 1 μM probe hemoglobinization and iron uptake Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2121400119
MDA-MB-231 cells 6.25 to 100 µg/mL 48 hours To evaluate anticancer efficacy, results showed that Hinokitiol-loaded phytosomal formulation had higher cytotoxicity than pure Hinokitiol, with an IC50 value of 5.7 µg/mL Int J Nanomedicine. 2024 Oct 12;19:10321-10339
MCF-7 cells 6.25 to 100 µg/mL 48 hours To evaluate anticancer efficacy, results showed that Hinokitiol-loaded phytosomal formulation had higher cytotoxicity than pure Hinokitiol, with an IC50 value of 18.6 µg/mL Int J Nanomedicine. 2024 Oct 12;19:10321-10339
normal liver cell line HL-7702 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the effect of β-Thujaplicin on normal liver cells, results showed that β-Thujaplicin had only a slight effect on the viability of HL-7702 cells at 400 nM Cell Death Dis. 2019 Mar 15;10(4):255.
human hepatoma cell lines HCCLM3 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the inhibitory effect of β-Thujaplicin on HCC cell growth, results showed that β-Thujaplicin significantly inhibited the viability of HCCLM3 cells in a dose-dependent manner Cell Death Dis. 2019 Mar 15;10(4):255.
human hepatoma cell lines SMMC-7721 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the inhibitory effect of β-Thujaplicin on HCC cell growth, results showed that β-Thujaplicin significantly inhibited the viability of SMMC-7721 cells in a dose-dependent manner Cell Death Dis. 2019 Mar 15;10(4):255.
human hepatoma cell lines HepG2 25, 50, 100, 200, 400 nM 24, 48, 72 h To evaluate the inhibitory effect of β-Thujaplicin on HCC cell growth, results showed that β-Thujaplicin significantly inhibited the viability of HepG2, SMMC-7721, and HCCLM3 cells in a dose-dependent manner Cell Death Dis. 2019 Mar 15;10(4):255.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Galleria mellonella Candida albicans-infected larvae Injection 2 μg/larva Single dose, observed for 7 days To evaluate the therapeutic effect of Hinokitiol on Candida albicans infection in vivo. Results showed that Hinokitiol significantly improved the survival rate of infected larvae and reduced fungal burden. J Adv Res. 2021 Jun 17;34:65-77
Belgrade rats DMT1-deficient rat model Oral gavage 1.5 mg/kg Single dose Promoted gut iron absorption in DMT1-deficient rats Science. 2017 May 12;356(6338):608-616
Nude mice HepG2 tumor xenograft model Intraperitoneal injection 5 mg/kg body weight Once daily for 15 days To evaluate the inhibitory effect of β-Thujaplicin on HepG2 tumor growth in vivo, results showed that β-Thujaplicin significantly reduced tumor volume and weight Cell Death Dis. 2019 Mar 15;10(4):255
Mice Myc-driven HCC model Intraperitoneal injection 25 mg/kg Twice a week from 4 to 9 weeks of birth To evaluate the effect of hinokitiol on Myc-driven HCC mouse model, results showed that hinokitiol significantly reduced tumor growth and CSC phenotypes, and downregulated the expression of UHRF1, GLI1, CD44, and CD133. Cell Death Dis. 2023 Jun 28;14(6):381
Mice FPN1-deficient mice Intraperitoneal injection 10 mg/kg Daily for 1 week Restore hemoglobinization and iron distribution Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2121400119
Nude mice HepG2 tumor xenograft model Intraperitoneal injection 5 mg/kg body weight Once daily for 15 days To verify the antitumor effect of β-Thujaplicin in vivo, results showed that β-Thujaplicin significantly inhibited the growth of HepG2 tumor xenografts Cell Death Dis. 2019 Mar 15;10(4):255.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.09mL

1.22mL

0.61mL

30.45mL

6.09mL

3.05mL

60.90mL

12.18mL

6.09mL

References

 

Historical Records

Categories